Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

GALVANI SWIFT GALVANI Scalable Workflow Innovation for Focal tES Therapy

Coordinator
Neuroelectrics Barcelona SL, Spain
Runs
1 October 2025 to 31 March 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101228702

What the project is doing

In the project's own words, from its summary on CORDIS.

The ERC Galvani project aims to revolutionize transcranial electrical brain stimulation (tES) therapy for epilepsy through acomputational breakthrough. By combining the expertise of clinical researchers and computational neuroscientists, the project willdevelop personalized brain stimulation solutions integrating magnetic resonance imaging (MRI) and stereoelectroencephalography(SEEG) data into advanced brain models. Neuroelectrics, a leader in medical neurotechnology, is implementing these solutions in apipeline that transforms patient data into individualized brain models and optimized tES protocols in focal epilepsy.

However,algorithms are highly dependent on the availability of high-quality MRI data and require time-consuming manual processing. Clinicaltranslation at scale faces two key challenges: first, image head cropping and uneven data quality in MRI scans, and second, brainlesions, which deviate from normal anatomy and require manual segmentation by trained operators. These result in a more complex,time-consuming, and costly personalization process.

To overcome these obstacles on the path from ground-breaking research toinnovation, the SWIFT project introduces an AI-based deep learning approach that enhances MRI data quality and automates thehandling of anatomical alterations, such as brain lesions, improving model accuracy and reducing processing time. To ensuretranslation into innovation, the project will develop a business strategy that addresses productization, regulatory, intellectualproperty, and commercialization challenges toward the goal of making model-driven tES therapy more scalable, cost-effective, andaccessible to a broader range of epilepsy patients.

Topics

Who is involved

OrganisationCityCountryRole
Neuroelectrics Barcelona SLBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI